> top > docs > PubMed:21054465 > annotations

PubMed:21054465 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
8261 23-29 GeneOrGeneProduct denotes CYP2C8 NCBIGene:1558
8262 33-45 DiseaseOrPhenotypicFeature denotes hypertensive MESH:D006973
8263 46-54 OrganismTaxon denotes patients NCBITaxon:9606
8264 141-147 GeneOrGeneProduct denotes CYP2C8 NCBIGene:1558
8265 167-200 GeneOrGeneProduct denotes cytochrome P450 (CYP) epoxygenase NCBIGene:1558
8266 210-226 ChemicalEntity denotes Arachidonic acid MESH:D016718
8267 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
8268 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
8269 337-349 DiseaseOrPhenotypicFeature denotes hypertension MESH:D006973
8270 451-457 GeneOrGeneProduct denotes CYP2C8 NCBIGene:1558
8271 563-575 DiseaseOrPhenotypicFeature denotes hypertensive MESH:D006973
8272 576-584 OrganismTaxon denotes patients NCBITaxon:9606
8273 633-639 GeneOrGeneProduct denotes CYP2C8 NCBIGene:1558
8274 690-696 GeneOrGeneProduct denotes CYP2C8 NCBIGene:1558
8275 730-738 OrganismTaxon denotes patients NCBITaxon:9606
8276 744-756 DiseaseOrPhenotypicFeature denotes hypertension MESH:D006973
8277 842-860 SequenceVariant denotes T deletion at 5063 c|DEL|5063|T
8278 881-896 SequenceVariant denotes C to T at 33468 c|SUB|C|33468|T
8279 982-994 DiseaseOrPhenotypicFeature denotes hypertensive MESH:D006973
8280 995-1003 OrganismTaxon denotes patients NCBITaxon:9606
8281 1058-1065 SequenceVariant denotes C35322C c|SUB|C|35322|C
8282 1082-1090 OrganismTaxon denotes patients NCBITaxon:9606
8283 1182-1189 SequenceVariant denotes C35322C c|SUB|C|35322|C
8284 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension MESH:D006973
8285 1411-1418 SequenceVariant denotes C35322T c|SUB|C|35322|T
8286 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive MESH:D006973
8287 1455-1463 OrganismTaxon denotes patients NCBITaxon:9606

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-111 Sentence denotes Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.
T2 112-209 Sentence denotes WHAT IS KNOWN AND OBJECTIVE: CYP2C8 is involved in the cytochrome P450 (CYP) epoxygenase pathway.
T3 210-350 Sentence denotes Arachidonic acid metabolites such as epoxyeicosatrienenoic acids and hydroxyeicosatetrenoic acids, produced may have a role in hypertension.
T4 351-522 Sentence denotes We aimed to develop a medium through-put method for screening samples of known and new mutations of CYP2C8 using denaturing high performance liquid chromatography (DHPLC).
T5 523-652 Sentence denotes METHODS: DNA samples from 200 subjects (hypertensive patients and healthy controls) were screened for SNPs in CYP2C8 using DHPLC.
T6 653-771 Sentence denotes Genotypes and allelic frequencies of CYP2C8 between the healthy controls and patients with hypertension were compared.
T7 772-796 Sentence denotes RESULTS AND DISCUSSIONS:
T8 797-907 Sentence denotes Six variants were detected and two were new; T deletion at 5063 and substitution of C to T at 33468 in exon 8.
T9 908-1004 Sentence denotes Differences in variant frequencies were detected between the controls and hypertensive patients.
T10 1005-1091 Sentence denotes The controls have significantly higher prevalence of C35322C compared to the patients.
T11 1092-1163 Sentence denotes The functional significance of the SNP at 35322 requires further study.
T12 1164-1236 Sentence denotes Having homozygous C35322C could be a protective factor for hypertension.
T13 1237-1264 Sentence denotes WHAT IS NEW AND CONCLUSION:
T14 1265-1384 Sentence denotes Denaturing high performance liquid chromatography is useful for population screening to identify new and existing SNPs.
T15 1385-1486 Sentence denotes A higher frequency of the C35322T SNP was observed among hypertensive patients than control subjects.
T16 1487-1587 Sentence denotes This potentially important observation requires confirmation and the clinical significance assessed.

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 1058-1065 SequenceVariant denotes C35322C
T2 1182-1189 SequenceVariant denotes C35322C
T3 1411-1418 SequenceVariant denotes C35322T

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 0-10 GeneOrGeneProduct denotes Mutational
T2 23-29 GeneOrGeneProduct denotes CYP2C8
T3 33-45 GeneOrGeneProduct denotes hypertensive
T4 72-76 GeneOrGeneProduct denotes high
T5 141-147 GeneOrGeneProduct denotes CYP2C8
T6 167-182 GeneOrGeneProduct denotes cytochrome P450
T7 184-187 GeneOrGeneProduct denotes CYP
T8 222-226 GeneOrGeneProduct denotes acid
T9 269-278 GeneOrGeneProduct denotes acids and
T10 302-307 GeneOrGeneProduct denotes acids
T11 337-349 GeneOrGeneProduct denotes hypertension
T12 392-398 GeneOrGeneProduct denotes method
T13 438-447 GeneOrGeneProduct denotes mutations
T14 451-457 GeneOrGeneProduct denotes CYP2C8
T15 475-479 GeneOrGeneProduct denotes high
T16 523-530 GeneOrGeneProduct denotes METHODS
T17 563-575 GeneOrGeneProduct denotes hypertensive
T18 633-639 GeneOrGeneProduct denotes CYP2C8
T19 675-686 GeneOrGeneProduct denotes frequencies
T20 690-696 GeneOrGeneProduct denotes CYP2C8
T21 744-756 GeneOrGeneProduct denotes hypertension
T22 931-942 GeneOrGeneProduct denotes frequencies
T23 982-994 GeneOrGeneProduct denotes hypertensive
T24 1212-1218 GeneOrGeneProduct denotes factor
T25 1223-1235 GeneOrGeneProduct denotes hypertension
T26 1276-1280 GeneOrGeneProduct denotes high
T27 1394-1403 GeneOrGeneProduct denotes frequency
T28 1442-1454 GeneOrGeneProduct denotes hypertensive

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 72-76 GeneOrGeneProduct denotes high
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 184-187 GeneOrGeneProduct denotes CYP
T6 222-226 GeneOrGeneProduct denotes acid
T7 337-349 GeneOrGeneProduct denotes hypertension
T8 392-398 GeneOrGeneProduct denotes method
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 475-479 GeneOrGeneProduct denotes high
T11 633-639 GeneOrGeneProduct denotes CYP2C8
T12 690-696 GeneOrGeneProduct denotes CYP2C8
T13 744-756 GeneOrGeneProduct denotes hypertension
T14 1212-1218 GeneOrGeneProduct denotes factor
T15 1223-1235 GeneOrGeneProduct denotes hypertension
T16 1276-1280 GeneOrGeneProduct denotes high
T17 1394-1403 GeneOrGeneProduct denotes frequency

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 33-45 DiseaseOrPhenotypicFeature denotes hypertensive D006973
T2 337-349 DiseaseOrPhenotypicFeature denotes hypertension D006973
T3 563-575 DiseaseOrPhenotypicFeature denotes hypertensive D006973
T4 744-756 DiseaseOrPhenotypicFeature denotes hypertension D006973
T5 982-994 DiseaseOrPhenotypicFeature denotes hypertensive D006973
T6 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension D006973
T7 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive D006973

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 141-147 GeneOrGeneProduct denotes CYP2C8
T3 167-182 GeneOrGeneProduct denotes cytochrome P450
T4 184-187 GeneOrGeneProduct denotes CYP
T5 451-457 GeneOrGeneProduct denotes CYP2C8
T6 633-639 GeneOrGeneProduct denotes CYP2C8
T7 690-696 GeneOrGeneProduct denotes CYP2C8

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 337-349 DiseaseOrPhenotypicFeature denotes hypertension 0005044
T2 744-756 DiseaseOrPhenotypicFeature denotes hypertension 0005044
T3 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension 0005044

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 337-349 DiseaseOrPhenotypicFeature denotes hypertension D006973
T2 744-756 DiseaseOrPhenotypicFeature denotes hypertension D006973
T3 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension D006973

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 337-349 DiseaseOrPhenotypicFeature denotes hypertension D006973
T2 744-756 DiseaseOrPhenotypicFeature denotes hypertension D006973
T3 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension D006973

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 167-182 ChemicalEntity denotes cytochrome P450 http://purl.obolibrary.org/obo/CHEBI_38559
T2 184-187 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T3 210-226 ChemicalEntity denotes Arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843
T4 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids ChemicalEntity
T5 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids ChemicalEntity

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 46-54 OrganismTaxon denotes patients
T2 576-584 OrganismTaxon denotes patients
T3 730-738 OrganismTaxon denotes patients
T4 995-1003 OrganismTaxon denotes patients
T5 1082-1090 OrganismTaxon denotes patients
T6 1455-1463 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T5 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids ChemicalEntity
T4 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids ChemicalEntity
T3 210-226 ChemicalEntity denotes Arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843
T2 184-187 ChemicalEntity denotes CYP http://purl.obolibrary.org/obo/CHEBI_38559
T1 167-182 ChemicalEntity denotes cytochrome P450 http://purl.obolibrary.org/obo/CHEBI_38559
T7 690-696 GeneOrGeneProduct denotes CYP2C8
T6 633-639 GeneOrGeneProduct denotes CYP2C8
T1312 451-457 GeneOrGeneProduct denotes CYP2C8
T65247 184-187 GeneOrGeneProduct denotes CYP
T13678 167-182 GeneOrGeneProduct denotes cytochrome P450
T53383 141-147 GeneOrGeneProduct denotes CYP2C8
T60092 23-29 GeneOrGeneProduct denotes CYP2C8
T25414 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension D006973
T9810 744-756 DiseaseOrPhenotypicFeature denotes hypertension D006973
T6284 337-349 DiseaseOrPhenotypicFeature denotes hypertension D006973
T5414 1455-1463 OrganismTaxon denotes patients
T46354 1082-1090 OrganismTaxon denotes patients
T16600 995-1003 OrganismTaxon denotes patients
T97472 730-738 OrganismTaxon denotes patients
T27071 576-584 OrganismTaxon denotes patients
T32716 46-54 OrganismTaxon denotes patients
T33311 1411-1418 SequenceVariant denotes C35322T
T6930 1182-1189 SequenceVariant denotes C35322C
T80582 1058-1065 SequenceVariant denotes C35322C

DisGeNET

Id Subject Object Predicate Lexical cue
T0 690-696 gene:1558 denotes CYP2C8
T1 744-756 disease:C0020538 denotes hypertension
R1 T0 T1 associated_with CYP2C8,hypertension

Allie

Id Subject Object Predicate Lexical cue
SS1_21054465_4_0 464-513 expanded denotes denaturing high performance liquid chromatography
SS2_21054465_4_0 515-520 abbr denotes DHPLC
AE1_21054465_4_0 SS1_21054465_4_0 SS2_21054465_4_0 abbreviatedTo denaturing high performance liquid chromatography,DHPLC

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 337-349 HP_0000822 denotes hypertension

biored-valid

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 46-54 OrganismTaxon denotes patients
T4 141-147 GeneOrGeneProduct denotes CYP2C8
T5 167-200 GeneOrGeneProduct denotes cytochrome P450 (CYP) epoxygenase
T6 210-226 ChemicalEntity denotes Arachidonic acid
T7 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T8 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T9 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T10 451-457 GeneOrGeneProduct denotes CYP2C8
T11 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T12 576-584 OrganismTaxon denotes patients
T13 633-639 GeneOrGeneProduct denotes CYP2C8
T14 690-696 GeneOrGeneProduct denotes CYP2C8
T15 730-738 OrganismTaxon denotes patients
T16 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T17 842-860 SequenceVariant denotes T deletion at 5063
T18 881-896 SequenceVariant denotes C to T at 33468
T19 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T20 995-1003 OrganismTaxon denotes patients
T21 1058-1065 SequenceVariant denotes C35322C
T22 1082-1090 OrganismTaxon denotes patients
T23 1182-1189 SequenceVariant denotes C35322C
T24 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T25 1411-1418 SequenceVariant denotes C35322T
T26 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive
T27 1455-1463 OrganismTaxon denotes patients

biored-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-10 SequenceVariant denotes Mutational
T2 23-29 GeneOrGeneProduct denotes CYP2C8
T3 46-54 DiseaseOrPhenotypicFeature denotes patients
T4 141-147 GeneOrGeneProduct denotes CYP2C8
T5 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T6 438-447 SequenceVariant denotes mutations
T7 451-457 GeneOrGeneProduct denotes CYP2C8
T8 525-526 SequenceVariant denotes T
T9 576-584 DiseaseOrPhenotypicFeature denotes patients
T10 625-629 SequenceVariant denotes SNPs
T11 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T12 801-809 SequenceVariant denotes variants
T13 844-852 SequenceVariant denotes deletion
T14 900-906 SequenceVariant denotes exon 8
T15 995-1003 DiseaseOrPhenotypicFeature denotes patients
T16 1058-1065 SequenceVariant denotes C35322C
T17 1411-1418 SequenceVariant denotes C35322T

biored-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-54 DiseaseOrPhenotypicFeature denotes hypertensive patients
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T7 451-457 GeneOrGeneProduct denotes CYP2C8
T8 515-520 ChemicalEntity denotes DHPLC
T9 532-535 ChemicalEntity denotes DNA
T10 563-584 DiseaseOrPhenotypicFeature denotes hypertensive patients
T11 625-629 SequenceVariant denotes SNPs
T12 633-639 GeneOrGeneProduct denotes CYP2C8
T13 646-651 ChemicalEntity denotes DHPLC
T14 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T15 801-808 SequenceVariant denotes variant
T16 1058-1065 SequenceVariant denotes C35322C
T17 1127-1130 SequenceVariant denotes SNP
T18 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T19 1411-1418 SequenceVariant denotes C35322T

biored-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-54 DiseaseOrPhenotypicFeature denotes hypertensive patients
T3 210-226 ChemicalEntity denotes Arachidonic acid
T4 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T5 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T6 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T7 625-629 SequenceVariant denotes SNPs
T8 842-860 SequenceVariant denotes T deletion at 5063
T9 865-906 SequenceVariant denotes substitution of C to T at 33468 in exon 8
T10 1058-1065 SequenceVariant denotes C35322C
T11 1127-1139 SequenceVariant denotes SNP at 35322
T12 1411-1422 SequenceVariant denotes C35322T SNP

biored-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 438-447 SequenceVariant denotes mutations
T10 451-457 GeneOrGeneProduct denotes CYP2C8
T11 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T12 625-629 SequenceVariant denotes SNPs
T13 633-639 GeneOrGeneProduct denotes CYP2C8
T14 690-696 GeneOrGeneProduct denotes CYP2C8
T15 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T16 801-809 SequenceVariant denotes variants
T17 842-852 SequenceVariant denotes T deletion
T18 865-887 SequenceVariant denotes substitution of C to T
T19 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T20 1058-1065 SequenceVariant denotes C35322C
T21 1127-1139 SequenceVariant denotes SNP at 35322
T22 1171-1189 SequenceVariant denotes homozygous C35322C
T23 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T24 1379-1383 SequenceVariant denotes SNPs
T25 1411-1422 SequenceVariant denotes C35322T SNP
T26 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive

biored-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 532-535 ChemicalEntity denotes DNA
T11 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T12 625-629 SequenceVariant denotes SNPs
T13 633-639 GeneOrGeneProduct denotes CYP2C8
T14 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T15 777-778 ChemicalEntity denotes T
T16 787-788 ChemicalEntity denotes C
T17 842-843 ChemicalEntity denotes T
T18 856-860 SequenceVariant denotes 5063
T19 891-896 SequenceVariant denotes 33468
T20 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T21 1058-1065 SequenceVariant denotes C35322C
T22 1127-1130 SequenceVariant denotes SNP
T23 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T24 1379-1383 SequenceVariant denotes SNPs
T25 1411-1418 SequenceVariant denotes C35322T
T26 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive

biored-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 61-110 ChemicalEntity denotes denaturing high performance liquid chromatography
T4 141-147 GeneOrGeneProduct denotes CYP2C8
T5 167-182 GeneOrGeneProduct denotes cytochrome P450
T6 210-226 ChemicalEntity denotes Arachidonic acid
T7 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T8 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T9 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T10 451-457 GeneOrGeneProduct denotes CYP2C8
T11 464-513 ChemicalEntity denotes denaturing high performance liquid chromatography
T12 515-520 ChemicalEntity denotes DHPLC
T13 532-535 ChemicalEntity denotes DNA
T14 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T15 625-629 SequenceVariant denotes SNPs
T16 633-639 GeneOrGeneProduct denotes CYP2C8
T17 646-651 ChemicalEntity denotes DHPLC
T18 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T19 842-860 SequenceVariant denotes T deletion at 5063
T20 865-896 SequenceVariant denotes substitution of C to T at 33468
T21 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T22 1058-1065 SequenceVariant denotes C35322C
T23 1127-1139 SequenceVariant denotes SNP at 35322
T24 1171-1189 SequenceVariant denotes homozygous C35322C
T25 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T26 1265-1314 ChemicalEntity denotes Denaturing high performance liquid chromatography
T27 1379-1383 SequenceVariant denotes SNPs
T28 1411-1422 SequenceVariant denotes C35322T SNP
T29 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive

biored-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T11 625-629 SequenceVariant denotes SNPs
T12 633-639 GeneOrGeneProduct denotes CYP2C8
T13 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T14 842-860 SequenceVariant denotes T deletion at 5063
T15 865-906 SequenceVariant denotes substitution of C to T at 33468 in exon 8
T16 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T17 1058-1065 SequenceVariant denotes C35322C
T18 1127-1139 SequenceVariant denotes SNP at 35322
T19 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T20 1379-1383 SequenceVariant denotes SNPs
T21 1411-1422 SequenceVariant denotes C35322T SNP
T22 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive

biored-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-54 DiseaseOrPhenotypicFeature denotes hypertensive patients
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-188 GeneOrGeneProduct denotes cytochrome P450 (CYP)
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-308 ChemicalEntity denotes hydroxyeicosatetrenoic acids,
T8 337-350 DiseaseOrPhenotypicFeature denotes hypertension.
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 532-535 ChemicalEntity denotes DNA
T11 625-629 SequenceVariant denotes SNPs
T12 633-639 GeneOrGeneProduct denotes CYP2C8
T13 690-696 GeneOrGeneProduct denotes CYP2C8
T14 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T15 842-852 SequenceVariant denotes T deletion
T16 881-887 SequenceVariant denotes C to T
T17 1058-1065 SequenceVariant denotes C35322C
T18 1127-1130 SequenceVariant denotes SNP
T19 1182-1189 SequenceVariant denotes C35322C
T20 1223-1236 DiseaseOrPhenotypicFeature denotes hypertension.
T21 1379-1384 SequenceVariant denotes SNPs.
T22 1411-1418 SequenceVariant denotes C35322T
T23 1442-1463 DiseaseOrPhenotypicFeature denotes hypertensive patients

biored-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 183-188 GeneOrGeneProduct denotes (CYP)
T6 210-226 ChemicalEntity denotes Arachidonic acid
T7 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T8 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T9 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T10 451-457 GeneOrGeneProduct denotes CYP2C8
T11 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T12 633-639 GeneOrGeneProduct denotes CYP2C8
T13 690-696 GeneOrGeneProduct denotes CYP2C8
T14 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T15 842-860 SequenceVariant denotes T deletion at 5063
T16 865-896 SequenceVariant denotes substitution of C to T at 33468
T17 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T18 1058-1065 SequenceVariant denotes C35322C
T19 1182-1189 SequenceVariant denotes C35322C
T20 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T21 1411-1418 SequenceVariant denotes C35322T
T22 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive

biored-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-54 DiseaseOrPhenotypicFeature denotes hypertensive patients
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-188 GeneOrGeneProduct denotes cytochrome P450 (CYP)
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 532-535 ChemicalEntity denotes DNA
T11 563-584 DiseaseOrPhenotypicFeature denotes hypertensive patients
T12 625-629 SequenceVariant denotes SNPs
T13 633-639 GeneOrGeneProduct denotes CYP2C8
T14 690-696 GeneOrGeneProduct denotes CYP2C8
T15 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T16 842-860 SequenceVariant denotes T deletion at 5063
T17 865-896 SequenceVariant denotes substitution of C to T at 33468
T18 982-1003 DiseaseOrPhenotypicFeature denotes hypertensive patients
T19 1058-1065 SequenceVariant denotes C35322C
T20 1127-1130 SequenceVariant denotes SNP
T21 1182-1189 SequenceVariant denotes C35322C
T22 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T23 1379-1383 SequenceVariant denotes SNPs
T24 1411-1418 SequenceVariant denotes C35322T
T25 1442-1463 DiseaseOrPhenotypicFeature denotes hypertensive patients

biored-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T11 633-639 GeneOrGeneProduct denotes CYP2C8
T12 690-696 GeneOrGeneProduct denotes CYP2C8
T13 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T14 842-860 SequenceVariant denotes T deletion at 5063
T15 865-896 SequenceVariant denotes substitution of C to T at 33468
T16 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T17 1058-1065 SequenceVariant denotes C35322C
T18 1127-1139 SequenceVariant denotes SNP at 35322
T19 1182-1189 SequenceVariant denotes C35322C
T20 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T21 1411-1418 SequenceVariant denotes C35322T
T22 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive

biored-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T11 633-639 GeneOrGeneProduct denotes CYP2C8
T12 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T13 842-896 SequenceVariant denotes T deletion at 5063 and substitution of C to T at 33468
T14 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T15 1058-1065 SequenceVariant denotes C35322C
T16 1127-1130 SequenceVariant denotes SNP
T17 1411-1418 SequenceVariant denotes C35322T

biored-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 46-54 OrganismTaxon denotes patients
T4 141-147 GeneOrGeneProduct denotes CYP2C8
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 553-561 OrganismTaxon denotes subjects
T11 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T12 576-584 OrganismTaxon denotes patients
T13 597-605 OrganismTaxon denotes controls
T14 625-629 SequenceVariant denotes SNPs
T15 633-639 GeneOrGeneProduct denotes CYP2C8
T16 690-696 GeneOrGeneProduct denotes CYP2C8
T17 717-725 OrganismTaxon denotes controls
T18 730-738 OrganismTaxon denotes patients
T19 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T20 842-860 SequenceVariant denotes T deletion at 5063
T21 865-896 SequenceVariant denotes substitution of C to T at 33468
T22 969-977 OrganismTaxon denotes controls
T23 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T24 995-1003 OrganismTaxon denotes patients
T25 1058-1065 SequenceVariant denotes C35322C
T26 1082-1090 OrganismTaxon denotes patients
T27 1127-1139 SequenceVariant denotes SNP at 35322
T28 1182-1189 SequenceVariant denotes C35322C
T29 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T30 1379-1383 SequenceVariant denotes SNPs
T31 1411-1418 SequenceVariant denotes C35322T
T32 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive
T33 1455-1463 OrganismTaxon denotes patients
T34 1477-1485 OrganismTaxon denotes subjects

biored-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 46-54 OrganismTaxon denotes patients
T4 141-147 GeneOrGeneProduct denotes CYP2C8
T5 167-182 GeneOrGeneProduct denotes cytochrome P450
T6 210-226 ChemicalEntity denotes Arachidonic acid
T7 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T8 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T9 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T10 451-457 GeneOrGeneProduct denotes CYP2C8
T11 553-561 OrganismTaxon denotes subjects
T12 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T13 576-584 OrganismTaxon denotes patients
T14 597-605 OrganismTaxon denotes controls
T15 625-629 SequenceVariant denotes SNPs
T16 633-639 GeneOrGeneProduct denotes CYP2C8
T17 717-725 OrganismTaxon denotes controls
T18 730-738 OrganismTaxon denotes patients
T19 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T20 842-860 SequenceVariant denotes T deletion at 5063
T21 865-896 SequenceVariant denotes substitution of C to T at 33468
T22 969-977 OrganismTaxon denotes controls
T23 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T24 995-1003 OrganismTaxon denotes patients
T25 1058-1065 SequenceVariant denotes C35322C
T26 1127-1139 SequenceVariant denotes SNP at 35322
T27 1182-1189 SequenceVariant denotes C35322C
T28 1223-1235 DiseaseOrPhenotypicFeature denotes hypertension
T29 1379-1383 SequenceVariant denotes SNPs
T30 1411-1422 SequenceVariant denotes C35322T SNP
T31 1442-1454 DiseaseOrPhenotypicFeature denotes hypertensive
T32 1455-1463 OrganismTaxon denotes patients
T33 1469-1476 OrganismTaxon denotes control
T34 1477-1485 OrganismTaxon denotes subjects

biored-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 23-29 GeneOrGeneProduct denotes CYP2C8
T2 33-45 DiseaseOrPhenotypicFeature denotes hypertensive
T3 141-147 GeneOrGeneProduct denotes CYP2C8
T4 167-182 GeneOrGeneProduct denotes cytochrome P450
T5 210-226 ChemicalEntity denotes Arachidonic acid
T6 247-274 ChemicalEntity denotes epoxyeicosatrienenoic acids
T7 279-307 ChemicalEntity denotes hydroxyeicosatetrenoic acids
T8 337-349 DiseaseOrPhenotypicFeature denotes hypertension
T9 451-457 GeneOrGeneProduct denotes CYP2C8
T10 563-575 DiseaseOrPhenotypicFeature denotes hypertensive
T11 625-629 SequenceVariant denotes SNPs
T12 744-756 DiseaseOrPhenotypicFeature denotes hypertension
T13 801-809 SequenceVariant denotes variants
T14 842-860 SequenceVariant denotes T deletion at 5063
T15 865-906 SequenceVariant denotes substitution of C to T at 33468 in exon 8
T16 982-994 DiseaseOrPhenotypicFeature denotes hypertensive
T17 1058-1065 SequenceVariant denotes C35322C
T18 1127-1139 SequenceVariant denotes SNP at 35322
T19 1411-1418 SequenceVariant denotes C35322T